StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Anika Therapeutics, Inc.
NasdaqGS:ANIK
Sector
Location
Market Cap
USD 161.34 M
Share Price
USD 11.25
Avg Daily Volume
75,631
Change (1 day)
0.00%
Change (1 year)
-55.64%
Change (YTD)
-31.65%
Anika Therapeutics, Inc. Enterprise Value to EBITDA (EV/EBITDA) on July 03, 2025
Anika Therapeutics, Inc. Enterprise Value to EBITDA (EV/EBITDA) is NA on July 03, 2025. EV/EBITDA ratio compares the enterprise value to the EBITDA; lower suggests more favorable company valuation.
-
Anika Therapeutics, Inc. 52-week low Enterprise Value to EBITDA (EV/EBITDA) is -8.21 on July 03, 2025, which is NA below the current Enterprise Value to EBITDA (EV/EBITDA).
-
Anika Therapeutics, Inc. 52-week low Enterprise Value to EBITDA (EV/EBITDA) is -210.46 on July 03, 2025, which is NA below the current Enterprise Value to EBITDA (EV/EBITDA).
-
Anika Therapeutics, Inc. average Enterprise Value to EBITDA (EV/EBITDA) for the last 52 weeks is -74.88.
Competitors
Merck & Co., Inc.
USD 80.96
MRK
-1.43
-1.74%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
USD 2.16
2196.HK
+0.01
0.48%
Globus Medical, Inc.
USD 59.17
GMED
-1.40
-2.31%
Grifols, S.A.
USD 12.46
GRF.MC
-0.04
-0.36%
Haisco Pharmaceutical Group Co., Ltd.
USD 6.27
002653.SZ
+0.13
2.12%
Regencell Bioscience Holdings Limited
USD 21.43
RGC
+11.07
106.85%
Hubei Jumpcan Pharmaceutical Co., Ltd.
USD 3.64
600566.SS
-0.01
-0.16%
Apeloa Pharmaceutical Co.,Ltd
USD 2.01
000739.SZ
+0.00
0.03%
Jubilant Pharmova Limited
USD 14.03
JUBLPHARMA.NS
-0.04
-0.30%
Shanghai Shyndec Pharmaceutical Co., Ltd.
USD 1.52
600420.SS
+0.01
0.77%
NovoCure Limited
USD 17.76
NVCR
-0.12
-0.67%
Tianjin Chase Sun Pharmaceutical Co.,Ltd
USD 0.55
300026.SZ
-0.01
-1.22%
Heilongjiang ZBD Pharmaceutical Co., Ltd.
USD 1.67
603567.SS
-0.06
-3.52%
Evotec SE
USD 8.39
EVT.DE
-0.28
-3.20%
AbbVie Inc.
USD 189.28
ABBV
-1.47
-0.77%
Novo Nordisk A/S
USD 68.84
NOVO-B.CO
-0.79
-1.13%
Roche Holding AG
USD 344.49
RO.SW
-3.19
-0.92%
Novartis AG
USD 121.35
NOVN.SW
-2.55
-2.06%
Abbott Laboratories
USD 134.44
ABT
+0.33
0.25%
AstraZeneca PLC
USD 139.36
AZN.L
-2.26
-1.60%
Key Data
| Date | Enterprise Value to EBITDA (EV/EBITDA) | Free Cash Flow Yield | Dividend Yield | Market Capitalization |
|---|
Competitors
Merck & Co., Inc.
USD 80.96
MRK
-1.43
-1.74%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
USD 2.16
2196.HK
+0.01
0.48%
Globus Medical, Inc.
USD 59.17
GMED
-1.40
-2.31%
Grifols, S.A.
USD 12.46
GRF.MC
-0.04
-0.36%
Haisco Pharmaceutical Group Co., Ltd.
USD 6.27
002653.SZ
+0.13
2.12%
Regencell Bioscience Holdings Limited
USD 21.43
RGC
+11.07
106.85%
Hubei Jumpcan Pharmaceutical Co., Ltd.
USD 3.64
600566.SS
-0.01
-0.16%
Apeloa Pharmaceutical Co.,Ltd
USD 2.01
000739.SZ
+0.00
0.03%
Jubilant Pharmova Limited
USD 14.03
JUBLPHARMA.NS
-0.04
-0.30%
Shanghai Shyndec Pharmaceutical Co., Ltd.
USD 1.52
600420.SS
+0.01
0.77%
NovoCure Limited
USD 17.76
NVCR
-0.12
-0.67%
Tianjin Chase Sun Pharmaceutical Co.,Ltd
USD 0.55
300026.SZ
-0.01
-1.22%
Heilongjiang ZBD Pharmaceutical Co., Ltd.
USD 1.67
603567.SS
-0.06
-3.52%
Evotec SE
USD 8.39
EVT.DE
-0.28
-3.20%
AbbVie Inc.
USD 189.28
ABBV
-1.47
-0.77%
Novo Nordisk A/S
USD 68.84
NOVO-B.CO
-0.79
-1.13%
Roche Holding AG
USD 344.49
RO.SW
-3.19
-0.92%
Novartis AG
USD 121.35
NOVN.SW
-2.55
-2.06%
Abbott Laboratories
USD 134.44
ABT
+0.33
0.25%
AstraZeneca PLC
USD 139.36
AZN.L
-2.26
-1.60%